Processes for the the identification and development of drugs. High-throughput methods that utilize combinatorial chemistry, genomics, and proteomics information are the starting point. Additional research to characterize lead compounds is followed by cli
The process of studying chemical entities in the laboratory to identify potential compounds for further pre-clinical and clinical development. This is the “research“ portion of drug research and development, or R & D.
The process by which a therapeutic agent is developed. This encompasses conceptual design, pre-clinical studies to substantiate the potential for clinical benefit, clinical trials to validate efficacy and safety, FDA approval, and drug production.
Identification of new drug targets and leads for treatments or preventions either by identifying molecules with desired biological effects or by screening agents using an indicator system to show efficacy.